https://www.taxtmi.com/news?id=39302 USFDA-approved cranial electrotherapy stimulation (CES) technology underlies the GoRoga wearable, patented as RogaLife in the USA and introduced into India. Promotional and clinical material cited a retrospective study and case vignettes asserting reductions in stress, anxiety, insomnia and related symptoms, clinician endorsements after demonstrations, and user satisfaction and continued use; marketing presents a broad set of intended uses including mental health, pain relief, and addiction-supportive claims. en-us Tue, 01 Apr 2025 14:31:02 +0530 Tue, 01 Apr 2025 14:31:02 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=39302 USFDA-approved cranial electrotherapy stimulation (CES) technology underlies the GoRoga wearable, patented as RogaLife in the USA and introduced into India. Promotional and clinical material cited a retrospective study and case vignettes asserting reductions in stress, anxiety, insomnia and related symptoms, clinician endorsements after demonstrations, and user satisfaction and continued use; marketing presents a broad set of intended uses including mental health, pain relief, and addiction-supportive claims. News - Tue, 01 Apr 2025 14:31:02 +0530 https://www.taxtmi.com/news?id=39302